Worldwide emergence of resistance to antifungal drugs challenges human health and food security.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29773744.
- Also identified by DOI 10.1126/science.aap7999.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonly used antifungal agents is unprecedented. The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation. The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments. One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chemicals. To avoid a global collapse in our ability to control fungal infections and to avoid critical failures in medicine and food security, we must improve our stewardship of extant chemicals, promote new antifungal discovery, and leverage emerging technologies for alternative solutions.
Medical subject headings
- Antifungal Agents
- Drug Resistance, Fungal
- Food Supply
- Fungi
- Infection Control
- Mycoses